Moreover, p38 transgenic mice also display attenuation of astrocyte migration and astrogliosis, which attenuate the overall damage induced by an ischaemic stroke.[113] As such, p38 seems to play a negative role in an ischaemic stroke and is therefore a potential post-stroke therapeutic target. Here, MAPK1 is linked to ischemic stroke.